These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8223981)

  • 1. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of injectable bromocriptine in patients with Cushing's disease.
    Invitti C; De Martin M; Danesi L; Cavagnini F
    Exp Clin Endocrinol Diabetes; 1995; 103(4):266-71. PubMed ID: 7584534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
    Zacharieva S; Matrosov P; Stoeva I; Kirilov G
    Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lack of effect of aging on dopaminergic inhibition of aldosterone and prolactin increase].
    Preis P; Luger A; Templ H; Tragl HK; Geyer G
    Z Gerontol; 1985; 18(4):241-3. PubMed ID: 3901563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
    Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
    Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variations of the renin aldosterone system in Cushing's disease (author's transl)].
    Bricaire H; Thibonnier M; Hautecouverture M; Corvol P; Luton JP
    Nouv Presse Med; 1980 Mar; 9(14):1007-9. PubMed ID: 6988802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach.
    Sowers J; Catania R; Paris J; Tuck M
    J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
    Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
    Demura R; Naruse M; Isawa M; Onoda N; Naruse K; Yamakado M; Demura H
    Endocrinol Jpn; 1992 Apr; 39(2):169-76. PubMed ID: 1396349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    O'Mullane N; Walker B; Jefferson J; Hipkin L; Diver M; Davis C
    J Endocrinol Invest; 1978 Oct; 1(4):355-7. PubMed ID: 229153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.